ADM's multiple accounting errors and SEC probe are ‘highly concerning' to investors [Fortune]
SOPHiA GENETICS SA - Ordinary Shares (SOPH)
Company Research
Source: Fortune
Now more financial mismanagement has caused ADM to abruptly postpone its third-quarter earnings call that was scheduled for Tuesday. The company announced on Monday that while testing internal controls, it identified additional misclassified transaction sales for each of its Ag Services and Oilseeds, Carbohydrate Solutions and Nutrition segments. Following a dialogue with the U.S. Securities and Exchange Commission (SEC), ADM will amend its Q1 and Q2 2024, and 2023 financial statements. Its stock price fell by 8% at market opening on Tuesday and down about 6% at market close. ADM has repeatedly violated Generally Accepted Accounting Principles, which have forced the company to restate its financial statements, according to Rick Warne, a professor of accounting at the University of San Diego's Knauss School of Business. “A series of accounting errors indicate that ADM has fundamental problems in its financial reporting processes that need to be resolved,” Warne said. For Q3, ADM
Show less
Read more
Impact Snapshot
Event Time:
SOPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SOPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SOPH alerts
High impacting SOPHiA GENETICS SA - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
SOPH
News
- SOPHiA GENETICS SA (NASDAQ: SOPH) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $11.00 price target on the stock.MarketBeat
- SOPHiA GENETICS Launches MSK-IMPACT® powered with SOPHiA DDM™ at AMP 2024 [Yahoo! Finance]Yahoo! Finance
- SOPHiA GENETICS Launches MSK-IMPACT® powered with SOPHiA DDM™ at AMP 2024PR Newswire
- SOPHiA GENETICS Launches MSK-IMPACT® powered with SOPHiA DDM™ at AMP 2024PR Newswire
- SOPHiA GENETICS Launches MSK-IMPACT® powered with SOPHiA DDM™ at AMP 2024PR Newswire
SOPH
Earnings
- 11/5/24 - Miss
SOPH
Sec Filings
- 12/19/24 - Form 144
- 12/19/24 - Form 144
- 12/13/24 - Form 144
- SOPH's page on the SEC website